z-logo
open-access-imgOpen Access
FM0807 decelerates experimental arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathways
Author(s) -
Nanwen Zhang,
Zhiwei Liu,
Hongbin Luo,
Weifang Wu,
Kaimei Nie,
Lin Cai,
Shuangyu Tan,
Xiaole Chen,
Ying Huang,
Jiaxing Liu,
Meina Lv,
Xin Zhang,
Yun Fan,
Yu-Ying Lin,
Shennan Ye,
Yang Liu,
Lixian Wu,
Jianhua Xu
Publication year - 2019
Publication title -
bioscience reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.938
H-Index - 77
eISSN - 1573-4935
pISSN - 0144-8463
DOI - 10.1042/bsr20182263
Subject(s) - arthritis , medicine , synovial fluid , tumor necrosis factor alpha , rheumatoid arthritis , curcumin , inflammation , pharmacology , pathogenesis , mapk/erk pathway , interleukin , chemistry , immunology , endocrinology , cytokine , osteoarthritis , kinase , pathology , biochemistry , alternative medicine
Rheumatoid arthritis (RA) is a chronic articular synovial inflammatory disease. The precise etiology underlying the pathogenesis of RA remains unknown. We aimed to investigate the inhibitory effect of curcumin analog FM0807 (curcumin salicylate monoester, 2-hydroxy-, 4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxo-1,6-heptadien-1-yl]-2-methoxyphenyl ester) on experimental RA and investigate its possible mechanisms of action.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom